IXICO PLC Logo

IXICO PLC

AI-powered neuroimaging and biomarker analytics for neurological clinical trials.

IXI | IL

Overview

Corporate Details

ISIN(s):
GB00BFXR4C20 (+1 more)
LEI:
2138005M1F59O6HWSA97
Country:
United Kingdom
Address:
4TH FLOOR, GRIFFIN COURT, EC1A 9PN LONDON
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

IXICO PLC is a clinical research company specializing in neuroscience imaging and biomarker analytics. Established in 2004, the firm provides services and technology to biopharmaceutical companies to support clinical trials for neurological disorders. At its core is a proprietary, AI-driven platform that deploys advanced, disease-specific algorithms to analyze neuroimaging and other clinical data. This generates reliable data and precision insights, enabling clients to accelerate research and development decision-making, de-risk clinical studies, and maximize the potential of their drug development programs. The company's services focus on reducing uncertainties in the discovery, development, and monitoring of new therapies for complex brain diseases.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-27 08:25
Report Publication Announcement
Notice of 2025 Full Year Results and IMC
English 14.7 KB
2025-11-17 08:10
Regulatory News Service
Clinical Trial Contract Win
English 15.9 KB
2025-11-03 15:40
Report Publication Announcement
Capital Markets Day Presentation and Video
English 15.0 KB
2025-10-16 08:00
Earnings Release
Trading Update
English 18.6 KB
2025-10-15 08:00
Regulatory News Service
New contract win and contract extension
English 16.2 KB
2025-08-12 08:00
Regulatory News Service
Contract Win
English 16.3 KB
2025-07-22 08:00
Regulatory News Service
Strategic Data Partnership with GAP
English 22.2 KB
2025-07-17 08:00
Earnings Release
Trading Update
English 16.8 KB
2025-06-13 09:03
Remuneration Information
Share option awards and PDMR Dealing
English 57.1 KB
2025-02-27 08:00
Regulatory News Service
Contract Win
English 15.1 KB
2025-02-12 08:00
Regulatory News Service
Further Validation of IXICO’s AI Imaging Platform
English 20.3 KB
2025-02-07 16:00
Director's Dealing
Issue of share options and PDMR dealing
English 43.7 KB
2025-01-24 15:16
Post-Annual General Meeting Information
Result of AGM
English 30.4 KB
2024-12-16 08:00
Regulatory News Service
Commercial agreement with PETNET Solutions Inc
English 12.6 KB
2024-12-10 08:00
Regulatory News Service
Contract Win
English 14.9 KB

Automate Your Workflow. Get a real-time feed of all IXICO PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IXICO PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IXICO PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Sweden
MBOLIC
Milton Essex Spolka Akcyjna Logo
Develops AI-powered, non-invasive systems for allergy diagnostics & personalized medicine.
Poland
MTN
Molecular Partners AG Logo
Pioneering DARPin protein drugs for complex diseases in oncology and virology.
Switzerland
MOLN
MorphoSys AG Logo
Biopharma company creating antibody therapies for oncology, with a focus on blood cancers.
Germany
MOR
N4 PHARMA PLC Logo
Developing a nanoparticle delivery system for advanced gene and vaccine therapies.
United Kingdom
N4P
NextGen Biomed Ltd. Logo
R&D of biotech medical devices for diabetes care and topical skin treatments.
Israel
NXGN
Nicox S.A. Logo
Developing innovative ophthalmology drugs for glaucoma and ocular hypertension.
France
COX
ONCIMMUNE HOLDINGS PLC Logo
Antibody biomarker discovery platform for pharma and biotech partners in oncology and autoimmune disease.
United Kingdom
ONC
OncoZenge AB Logo
Developing a non-opioid lozenge for oral pain relief in cancer patients.
Sweden
ONCOZ

Talk to a Data Expert

Have a question? We'll get back to you promptly.